119P Long-term safety evaluation of roginolisib (formerly IOA-244), a highly selective phosphoinositide 3-kinase inhibitor delta (PI3Kδ), in a phase I first-in-human (FIH) study

Autor:	A.M. Di Giacomo, P. Mason, R. Snijder, A. Abdul-Ahad, M. Lahn, L. Van der Veen, T. Hammett, R. Zorrilla, C.A. Pickering, M. Durini, M. Simonelli, C. Carlo-Stella, A. Santoro, P. Spiliopoulou, T.R.J. Evans, M. Maio
Rok vydání:	2023
Předmět:	Cancer Research Oncology
Zdroj:	ESMO Open. 8:101065
ISSN:	2059-7029
DOI:	10.1016/j.esmoop.2023.101065
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6e441ecea0d0c099b4706e970a428715 https://doi.org/10.1016/j.esmoop.2023.101065 Zobrazit plný text záznamu